On September 11, 2017, Seeking Alpha published an article asserting that: (1) in June 2017, the Company was rejected for licensure in its home state of Florida, as the regulator uncovered multiple undisclosed legal actions against multiple Health Insurance Innovations insiders; and (2) the Company privately warned the regulator of a disastrous “domino effect” of denials spreading to other stated where Health Insurance Innovations does business, yet failed to disclose this anticipated impact to investors in its regulatory filings. Following this news, the stock price of the Company fell $6.55 per share, or almost 22%.

A number of class actions accusing Health Insurance Innovations’ executives of securities fraud have been filed in federal courts.

If you purchased or otherwise acquired Health Insurance Innovations shares and suffered a loss, continue to hold shares, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Melissa Fortunato by email at [email protected], or telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you.